A previously described bluetongue virus (BTV) serogroup polymerase chain reaction (PCR) assay was applied to clinical samples. The sensitivity of the BTV serogroup PCR was increased by the use of nonradioactive chemiluminescent hybridization. Unfractionated whole blood samples from rams experimentally inoculated with cell culture-adapted BTV-11 UC-8 were analyzed by virus isolation (VI) on Vero cells and PCR. VI and PCR were in agreement, with the exception of 3 blood samples that were VI negative and PCR positive. In semen spiked with BTV-11 UC-8, PCR detected as little as 1.6 x 10 2 plaque-forming units of BTV/ ml of semen. BTV in the spleen of a sheep submitted for necropsy for suspect BTV infection was detected by both PCR and VI in embryonated chicken eggs. BTV PCR with nonradioactive chemiluminescent hybridization resulted in a level of sensitivity comparable to that of VI and likly more sensitive than VI on Vero cells for blood. This BTV PCR has great promise for rapid, sensitive, and specific detection of active BTV infection in a variety of clinical samples.
Bluetongue virus (BTV) is an arthropod-borne orbivirus that infects wild and domestic ruminants. Bluetongue virus infection is economically significant because of morbidity and mortality among clinically affected animals and restrictions on international movement of animals and germplasm that have not been certified BTV free. 14 Animal and germplasm protocols for BTV-free certification are currently being reevaluated (B.I. Osburn, personal communication). Competitive enzyme-linked immunosorbent assay (cELISA) formats will prove useful for determination of exposure to BTV. However determination of active BTV infection in seropositive animals and their germplasm will still require a costly, lengthy protocol involving virus isolations and serology. Polymerase chain reaction (PCR), 13 a technique used to exponentially amplify targeted nucleic acid sequences, has great promise for facilitating detection of active BTV infection. Sensitive detection of the viral RNA from a wide spectrum of BTV serotypes from the United States and Israel using PCR amplification of viral RNA and radioactive dot hybridization detection of the BTV-specific PCR product have been reported. l This paper outlines application of the previously reported BTV PCR protocol, modified with nonradioactive hybridization detection of the BTVspecific PCR product, to the detection of BTV in blood, semen, and tissue.
Materials and methods

Clinical samples
Blood. As part of a larger study, 6 adult rams were inoculated intradermally/subcutaneously (ID/SC) with 10 7 -10 8 plaque-forming units (pfu) of tissue culture-adapted BTV serotype 11 UC-8 strain. 19 Blood was collected in heparinized vacutainer tubes on the day of inoculation (postinoculation day [PID] 0) and on PIDs 3, 5, 7, 9, 11, and 14. One experimental ram was euthanized on each of the following PIDs: 3, 5, 7, 9, 11, and 14. Upon return to the laboratory, the heparinized blood was washed 3 times with a volume of phosphate-buffered saline (PBS) + 1% penicillin/streptomycin equal to the volume of plasma removed. After the last wash, the PBS + penicillin/ streptomycin was removed and blood cells were lysed in a volume of 2 mM Tris, pH 8.0, equal to the volume of PBS removed.
Semen. Semen was collected aseptically from an experimental ram by electroejaculation before inoculation on PID 0. Semen was diluted 1:2 with PBS + 2% penicillin/streptomycin immediately upon return to the laboratory and stored at -70 C. The semen was thawed later, and 1 aliquot of the 1:2 diluted semen was diluted 1:10 in PBS, resulting in a final dilution of 1:20. Additional aliquots of the 1:2 diluted semen were diluted with PBS and spiked with BTV-11 UC-8 such that the final dilution of the semen in all aliquots was 1:20, and an individual semen aliquot contained either 1.6 x 10 7 , 1.6 x 10 6 , 1.6 x 10 5 , 1.6 x 10 4 , 1.6 x 10 3 , 1.6 x 10 2 , or 16 pfu BTV-11 UC-8/ml of semen.
Tissue. A sample of spleen was collected from a sheep submitted for necropsy for suspect BTV infection.
Virus isolation
The lysed blood was inoculated onto Vero cell monolayers for virus isolation (VI) and plaque titration. 17 The remaining lysed blood was stored at 4 C for later analysis by PCR.
The tissue sample was homogenized 1:10 w/v in minimal essential medium a and clarified by centrifugation at 1,500 x g for 20 min. The tissue homogenate was inoculated intravenously (IV) into embryonated chicken eggs (ECE). 6 The BTV isolate was serotyped by plaque inhibition. 17 The remaining tissue homogenate was stored at 4 C for later analysis by PCR.
The unspiked 1:20 diluted semen was inoculated IV into ECE. 6
Nucleic acid extraction from clinical samples
A volume of 3 M NaOAc, pH 5, was added to 250 µ1 of the lysed blood, 1:20 dilute semen, or tissue homogenate, bringing the NaOAc concentration to 0.1 M. The sample was then diluted 1:2 with 250 µ1 of 0.1 M NaOAc, pH 5. Fifty microliters of 10% sodium dodecyl sulfate (SDS) and 2.5 µ1 of 20 µg/ml proteinase K b was added. The mixture was incubated for 15 min at 37 C followed by an incubation for 4 min at 60 C. The mixture was sequentially extracted with an equal volume of 0.1 M NaOAc (pH 5)-buffered phenol and 0.1 M Tris (pH 8.0)-buffered phenol. Total nucleic acid was ethanol precipitated and resuspended in 15-20 µ1 of doubledistilled water. Five microliters of this solution was used in the BTV PCR.
PCR
The BTV PCR was performed as previously described. 1 Twenty microliters of the PCR reaction was run on a 2% agarose c gel and stained with ethidium bromide. The BTVspecific PCR product was 251 base pairs (bp) long.
Probe preparation
A pair of 20-mer oligonucleotide primers internal to the oligonucleotide primer pair used for serogroup detection of BTV was designed from the published sequence for genome segment 10 from BTV-11. 4 Primer 1 consisted of bases 34-53 of the positive strand of genome segment 10: 5' GATCCAAAGGTTCGAAGAAG 3'. Primer 2 was derived from the complementary strand between bases 197 and 216: 5' CCAGTTGTGTTTGACATCGC 3'. The oligonucleotide primer pair was synthesized on a DNA Synthesizer' and column purified d as per the manufacturer's instructions. BTV PCR using this primer pair resulted in a 182-bp PCR product internal to the primer annealing sites of the BTV-specific 251-bp PCR product. The 182-bp PCR product was purified using DNA binding beads e according to the manufacturer's instructions and used as a probe for Southern blot hybridizations.
Southern blot hybridization
BTV-specific PCR products from the agarose gel were vacuum blotted f onto 2-µm pore size nylon membrane. g Denaturation and neutralization of agarose gels and transfers to nylon membranes took place under vacuum at 40 mmHg. Agarose gels were denatured for 4 min in 0.5 M NaOH + 1.5 M NaCl and neutralized in LO M Tris + 2.0 M NaCl, pH 5.0, for 4 min. DNA was transferred to the nylon membrane in 20 x standard saline citrate (SSC) for 1 hr. Southern blotted nucleic acid was cross-linked by ultraviolet light to the nylon membrane. Chemiluminescent hybridization was performed using a kit h according to the manufacturer's instructions. The 182bp probe prepared by PCR was heat denatured and directly labeled with peroxidase in the presence of glutaraldehyde. Southern blots were prehybridized with hybridization buffer containing blocking reagent and 0.5 M NaCl at 42 C for 45 min. The peroxidase-labeled probe was added to the prehybridization buffer, and hybridization took place at 42 C overnight. Following hybridization, the membranes were washed 2 times at 42 C for 20 min each in 6 M urea, 0.5 x SSC, and 0.1% SDS. The membranes were then washed 2 times for 5 min each in 2 x SSC. Detection reagent was applied to the membranes for 1 min. The membranes were wrapped in Saran wrap and exposed to X-ray film with an intensifying screen for 1-90 min. Figure 1 demonstrates detection of BTV in blood from experimentally infected ram no. 389, which was euthanized on PID 11. With agarose gel detection of specific PCR product, BTV was detected in blood samples from PIDs 5, 7, 9, and 11. With chemiluminescent hybridization of Southern-blotted specific PCR product, BTV was detected in blood samples from PIDs 3. 5, 7, 9, and 11. BTV titers from the blood of ram no. 389 were 0, 30 pfu/ml, 8.7 x 10 4 pfu/ml, 5.7 x 10 4 pfu/ml, 1.0 x 10 4 pfu/ml, and 5.9 x 10 2 pfu/ml on PIDs 0, 3, 5, 7, 9, and 11, respectively. Table 1 summarizes detection of BTV in the blood of experimentally infected rams using PCR with che- miluminescent hybridization and VI. PCR and VI results were generally in agreement. However, samples from ram no. 341 on PID 3 and ram no. 426 on PIDs 5 and 7 were VI negative and PCR positive. BTV titers from all experimental animals ranged from 30 to 8.7 x 10 4 pfu/ml. Figure 2 demonstrates the detection of BTV in semen spiked with known quantities of BTV-11 UC-8. The unspiked semen was negative for BTV by VI in ECE and PCR. With agarose gel detection of specific PCR product, BTV was indentified from semen spiked with as little as 1.6 x 10 4 pfu BTV/ml of semen. In Fig. 2B , strong chemiluminescent signals were detected up to lane e ( 1.6 x 10 4 pfu BTV/ml of semen). Faint but identifiable signals were detected from as little as 1.6 x 10 2 pfu BTV/ml of semen (lane c). Figure 3 shows detection of BTV in spleen homogenate. The BTV-specific 251-bp PCR product amplified from a spleen homogenate was visible on an agarose gel (hybridization data in agreement with the agarose gel is not shown). BTV was isolated from the spleen homogenate by ECE and was identified as BTV serotype 17.
Results
Discussion
Detection of BTV in blood samples from experimentally inoculated rams was similar with BTV PCR with chemiluminescent hybridization and with VI (Table 1). PCR detected BTV in the sample with the lowest viral titer of 30 pfu/ml (Fig. 1) . However, VI-negative and PCR-positive results from ram no. 341 PID 3 and ram no. 426 PIDs 5 and 7 suggested that PCR was more sensitive than VI on Vero cells. In this study, all experimentally infected rams, except ram nos. 341 and 426, were viremic (by VI) as early as PID 3 (ram no. 389) and generally by PID 5. In other studies of experimental intradermal/subcutaneous inoculations of BTV in sheep, viremia documented by VI was demonstrated by PID 3-6. 9, 11, 16 The results of our study, including data that all PID 0 blood samples were both VI and PCR negative ( Table 1) , and of previous studies of experimental infections of BTV in the ovine strongly suggested that the VI results for ram no. 341 PID 3 and ram no. 426 PIDs 5 and 7 were false negatives. These findings support the likelihood that the sensitivity of PCR with chemiluminescent hybridization for detection of BTV in blood is greater than that of VI on Vero cells.
The reason for the false negatives from blood on Vero cell culture may be related to the relative insensitivity of Vero cells to BTV infection. A study evaluating the susceptibility of 14 cell lines to BTV inoculation determined that calf pulmonary artery endothelium cell line (CPAE) was the most sensitive cell line for BTV isolation. However, CPAE cells were less sensitive than ECE. C6/36, BHK-21, and Vero cells were approximately 10 times less sensitive than CPAE cells. 20 BTV-11 UC-8 has been adapted to Vero cells, 19 and isolation of this BTV strain on Vero cell culture should yield acceptable levels of sensitivity. Vero, BHK-21, and C6/36 cell lines are commonly used for BTV isolation. 8 However, Vero cell culture may not have been sensitive enough to identify BTV detected by PCR. Studies to evaluate the BTV PCR against other VI systems, including ECE and sheep, are in progress.
Isolation of BTV from the semen of cattle, especially during peak BTV viremia, is well documented. 2, 7, 10, 15 Reports of BTV titers in semen are scant. In 2 studies using bulls experimentally infected with tissue cultureadapted BTV, seminal BTV titers ranged from 10 2.3 to 10 5.5 chicken embryo intravascular lethal dose-50 (CEIVLD 50 )/ml and 10 1.7 to 10 5.7 tissue culture infective dose-50 (TCID 50 )/ml on Vero cells. 3, 7 Based on a conversion of 1 LD 50 = 0.7 infectious units (iu) or pfu, 5 the viral titers convert to 71-2.2 x 10 5 iu/ml on ECE and 35-3.5 x 10 5 pfu/ml on Vero cell culture. The BTV PCR with chemiluminescent hybridization detected as little as 1.6 x 10 2 pfu BTV-11 UC-8 in 1 ml of spiked semen (Fig. 2 ). This level of sensitivity was interpreted as well within the range of VI. In the previous studies, semen inocula were sonicated before VI. By disrupting cells and potentially making virus more accessible, sonication of semen samples prior to nucleic acid extraction and PCR may increase the sensitivity of PCR with semen. Because BTV is probably cell associated in semen, 7 washing of seminal cells prior to nucleic acid extraction and PCR or prior to sonication of seminal cells followed by nucleic acid extraction and PCR may also be useful.
Data from application of the BTV PCR to blood and semen demonstrated increased sensitivity with hybridization detection of the BTV-specific PCR product versus agarose gel detection (Figs. 1, 2) . These data corroborate the previous report 1 and emphasize the need for hybridization to confirm the presence or ab-sence of BTV-specific PCR product. In addition, the hybridization step will ensure the specificity of the PCR product.
BTV was detected by both PCR and VI in ECE in spleen homogenate from a sheep submitted for necropsy. The BTV isolate was serotyped as BTV-17. The BTV-specific 251-bp PCR product from the spleen homogenate was identified on agarose gel, which was approximately 100 times less sensitive than PCR with hybridization ( Fig. 2 ). 1 These results indicated a relatively high titer of BTV in the spleen homogenate.
The level of sensitivity achieved with our BTV PCR compares favorably with that of previously reported PCR protocols for BTV detection in blood. 12, 18 This PCR protocol utilized lysed whole blood, the sample commonly used for VI, whereas previously reported protocols required the isolated erythrocyte fraction or buffy coat. In addition, 1 of these previous reports noted that BTV could not be detected from whole blood with their PCR protocol. 12 This report also documents the first detection using PCR of BTV from tissue homogenate and spiked semen. The semen and tissue homogenates used were identical or very similar to samples commonly used for VI.
With the BTV PCR protocol described here, preliminary results from agarose gels can be obtained 1 day after sample submission. Final results with nonradioactive, chemiluminescent hybridization can be obtained within 2.5 days after sample submission.
The described BTV PCR reproducibly and specifically identified BTV in a variety of clinical samples, including unfractionated whole blood, semen, and tissue homogenate. With nonradioactive chemiluminescent hybridization detection of the BTV-specific PCR product, the level of sensitivity of the BTV PCR was comparable to VI and in the case of whole blood may be more sensitive than VI on Vero cells. In addition, PCR results (including chemiluminescent hybridization) can be obtained within 2.5 days, compared with 5 days to several weeks with VI. Continued application of this BTV PCR to larger numbers of clinical samples from the field and experimental animals is in progress. 
